FIELD: chemistry.
SUBSTANCE: invention relates to specific derivatives of bicyclic amides disclosed in the claim, as well as a pharmaceutical composition.
EFFECT: compounds having protein kinase inhibiting activity, meant for use in treating protein kinase-dependant diseases, preferably proliferative diseases such as tumorous diseases.
13 cl, 115 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROBICYCLIC CARBOXAMIDES AS KINASE INHIBITORS | 2007 |
|
RU2436785C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2005 |
|
RU2401265C2 |
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
CYTOKINE INHIBITORS | 2004 |
|
RU2394029C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEIN TYROSINE KINASE INHIBITORS | 2006 |
|
RU2386630C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2368602C2 |
AZETINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | 2007 |
|
RU2447070C2 |
2-AZA-BICYCLO[3,1,0]HEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | 2007 |
|
RU2460732C2 |
BICYCLIC AMIDES AS KINASE INHIBITORS | 2005 |
|
RU2416611C2 |
NEW DIAMIDES PYRIMIDIN-4,6 OF DICARBOXYLIC ACID FOR SELECTIVE INHIBITION OF COLLAGENASES | 2003 |
|
RU2344129C2 |
Authors
Dates
2012-04-20—Published
2005-09-14—Filed